Plain-English translation of NCT06632431 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is reviewing the medical records and tissue samples of women diagnosed with endometrial cancer to compare how well two different staging systems — an older one from 2009 and a newer one from 2023 — predict patient outcomes. The newer system includes information about the molecular characteristics of the cancer (similar to how breast cancer is now staged), which may help doctors better understand each patient's individual cancer and recommend the most appropriate treatment.
Endometrial cancer is the most common gynecological cancer in older women, and how doctors stage and classify the disease directly affects treatment decisions and survival predictions. The new staging system is designed to be more accurate and personalized than the previous system, but researchers need to study real patient cases to confirm that it truly helps doctors make better decisions and improves outcomes.
You likely qualify if…
You likely don't qualify if…
Your participation in this study is non-invasive — researchers will review your existing medical records, pathology reports, and tissue samples that were already collected during your cancer treatment. There are no additional visits, procedures, or treatments required. The study team will analyze your information to compare how the two staging systems classify your cancer and track how you responded to treatment over your two-year follow-up period.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Egypt
Sponsor
Assiut University
Enrollment target
~110 participants
Started
October 2024
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yousra H Abdelghafour, MBBCH
Assiut University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.